The global Prefilled Syringes Market accrued earnings worth approximately 6.1 (USD Billion) in 2021 and is predicted to gain revenue of about 17.2(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2022 to 2028.
The global Prefilled Syringes Market accruedearnings worth approximately 6.1 (USD Billion) in 2021 and ispredicted to gain revenue of about 17.2(USD Billion) by 2028, isset to record a CAGR of nearly 9.5% over the period from 2022 to2028. The study provides assessment and analysis of the Prefilled Syringes Market on a global & regionallevel. It offers a comprehensive assessment of the marketcompetition, constraints, revenue estimates, opportunities,evolving trends, and industry-validated data. The report provideshistorical data from 2018 to 2021 along with a forecast from 2022to 2028 based on revenue (USD Billion).
COVID-19 pandemic has favorable impact on prefilled syringes market with large use of vaccines for preventing COVID. Increase inpharmaceutical packaging activities during COVID crises & at time(of peak) of the pandemic (period) has enhanced sale of prefilledsyringes. Manufacturers have increased their production capacity tofulfill escalating demand for prefilled syringes. Citing aninstance, the U.S. administration signed an agreement of about USD139 million with prefilled syringe manufacturers.
Prefilled Syringes are injectable medicine delivery containersthat are devised for drug administration through parental route.Furthermore, pharmaceutical firms are considering prefilledsyringes as an effective tool for delivering slew of injectablemedicines including bio-similars and biologics. Reportedly, theseproducts facilitate easy & quick drug delivery during emergencies.
The prefilled syringes help in reducing drug contamination risksthrough insertion of a drug vial for drawing out a dose.Elimination of this medicine contamination risk with apre-sterilized syringe enhances safety along with removing theadditional procedure of on-site vial cleaning as well asde-pyrogenation.
Massive necessity of prefilled syringes is owing to rise inoccurrence of chronic ailments, technological breakthroughs, andsurging acceptance of self-injecting parenteral equipment willdrive market trends. Furthermore, favorable government laws overuse of prefilled syringes in healthcare sector including clinics,hospitals, and ambulatory surgical units will open new vistas ofgrowth for prefilled syringes market. Apart from this, prefilledsyringes help in making injections easy, safe, and accurate forboth subjects and physicians. This will create new growth avenuesfor prefilled syringes industry.
Moreover, these medical devices have evolved as one of therapidly emerging options for unit dose of medicine withpharmaceutical sector seeking user-friendly drug delivery methods.This will drive market trends. In addition to this, prefilledsyringes are compatible with auto-injection tools & securedequipment. Furthermore, these medical products finds array ofapplications in therapeutic sector that include therapeuticproteins, vaccines, and blood stimulants. Elimination of dosingerrors & user-friendliness are some of beneficial features ofprefilled syringes. These features differentiate it fromconventional syringes and hence they are preferred over latter.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and MiddleEast & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain,China, India, Japan, South Korea, Brazil, Argentina, GCC Countries,and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companiesupon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s fiveforces analysis, PEST analysis, value chain analysis, regulatorylandscape, market attractiveness analysis by segments and region,company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact researchneeds. |
Europe Prefilled Syringes Market To Retain DominanceOver 2022-2028
Regional market growth over forecasting timespan can be creditedto rise in use of biological medicines in healthcare sector alongwith breakthroughs witnessed in prefilled syringe systems forfulfilling unmet requirements to treat chronic ailment in Europe.Increase in use of biologics for treating chronic disorders alongwith need for strong drug packaging in sophisticated containerenclosures & drug delivery systems will spur expansion of prefilledsyringes industry in European continent. Surge in demand forprefilled syringe to safely deliver bio-similar will expand size ofprefilled syringes market in region. Launching of newproducts by giant players coupled with large-scale acceptance ofthis medical equipment by healthcare service providers willpromulgate progression of prefilled syringes market in Europeanzone.
Some of the giant participants have a long-lasting impact onmarket and are also profiled in our report. They are Bespak, SchottAG, Nipro Corporation, West Pharmaceutical Services, Inc., VetterPharma International GmbH, Baxter International, Inc., Becton,Dickinson & Company, Unilife Corporation, Stevanato Group, andGerresheimer AG.
By Material
By Type
By Application
By Region
FrequentlyAsked Questions
Massive need of prefilled syringes is due to rise in occurrence of chronic disorders, technological innovations, and adoption of self-injecting parenteral device. This will enlarge expansion of Prefilled Syringes Market over coming period.
According to Zion market research report, The global Prefilled Syringes Market accrued earnings worth approximately 6.1 (USD Billion) in 2021 and is predicted to gain revenue of about 17.2(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2022 to 2028.
Europe will contribute humongously towards the global market revenue over the projected timespan. Expansion of Prefilled Syringes Market in the continent can be attributed to introduction of new products by mammoth participants along with large-scale adoption of this medical device by healthcare experts.
The key market participants leveraging business sphere include Bespak, Schott AG, Nipro Corporation, West Pharmaceutical Services, Inc., Vetter Pharma International GmbH, Baxter International, Inc., Becton, Dickinson & Company, Unilife Corporation, Stevanato Group, and Gerresheimer AG.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed